Prodia Diagnostic Line Tbk vs Cerestar Indonesia Tbk. — how do they compare? Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 28.43M 24h volume), while Cerestar Indonesia Tbk. trades at Rp168 (market cap 1.34T, 256.3K 24h volume). The key difference: Cerestar Indonesia Tbk. is far larger — about 2.8× Prodia Diagnostic Line Tbk's market cap, and Prodia Diagnostic Line Tbk is more actively traded (28.43M versus 256.3K). Which is the better fit depends on your goals.
| PRDL | TRGU | |
|---|---|---|
Market Cap | 470.58B | 1.34T |
Volume | 28.43M | 256.3K |
Lot | 284.34K | 2.56K |
Turnover | 7.8B | 43.19M |
Average Price | 274.19 | 168.52 |
Value | 7.8B | 43.19M |
Indicative Equilibrium Price | 270 | 168 |
Indicative Equilibrium Volume | 2.1K | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →PT. Cerestar Indonesia Tbk (the Company) was established based on Notarial Deed No. 2 datedAugust 30, 2020 of Dwi Yulianti, S.H., notary in Jakarta The Company started its commercial operations in 2021.
Read more on TRGU →